vs

Side-by-side financial comparison of FRP HOLDINGS, INC. (FRPH) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.

ROCKWELL MEDICAL, INC. is the larger business by last-quarter revenue ($18.3M vs $10.9M, roughly 1.7× FRP HOLDINGS, INC.). FRP HOLDINGS, INC. runs the higher net margin — 1.3% vs -3.0%, a 4.3% gap on every dollar of revenue. On growth, FRP HOLDINGS, INC. posted the faster year-over-year revenue change (3.6% vs -25.6%). ROCKWELL MEDICAL, INC. produced more free cash flow last quarter ($2.2M vs $-21.5M). Over the past eight quarters, FRP HOLDINGS, INC.'s revenue compounded faster (3.8% CAGR vs -10.1%).

FRP Advisory is a business advisory firm based in the United Kingdom, providing restructuring, corporate finance, debt advisory, forensic accounting and financial advisory and is one of the UK’s largest specialists in the area of corporate restructuring.

Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).

FRPH vs RMTI — Head-to-Head

Bigger by revenue
RMTI
RMTI
1.7× larger
RMTI
$18.3M
$10.9M
FRPH
Growing faster (revenue YoY)
FRPH
FRPH
+29.3% gap
FRPH
3.6%
-25.6%
RMTI
Higher net margin
FRPH
FRPH
4.3% more per $
FRPH
1.3%
-3.0%
RMTI
More free cash flow
RMTI
RMTI
$23.7M more FCF
RMTI
$2.2M
$-21.5M
FRPH
Faster 2-yr revenue CAGR
FRPH
FRPH
Annualised
FRPH
3.8%
-10.1%
RMTI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FRPH
FRPH
RMTI
RMTI
Revenue
$10.9M
$18.3M
Net Profit
$139.0K
$-554.0K
Gross Margin
21.1%
Operating Margin
15.4%
-2.2%
Net Margin
1.3%
-3.0%
Revenue YoY
3.6%
-25.6%
Net Profit YoY
-91.8%
26.7%
EPS (diluted)
$0.03
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FRPH
FRPH
RMTI
RMTI
Q4 25
$10.9M
$18.3M
Q3 25
$10.8M
$15.9M
Q2 25
$10.8M
$16.1M
Q1 25
$10.3M
$18.9M
Q4 24
$10.5M
$24.7M
Q3 24
$10.6M
$28.3M
Q2 24
$10.5M
$25.8M
Q1 24
$10.1M
$22.7M
Net Profit
FRPH
FRPH
RMTI
RMTI
Q4 25
$139.0K
$-554.0K
Q3 25
$662.0K
$-1.8M
Q2 25
$578.0K
$-1.5M
Q1 25
$1.7M
$-1.5M
Q4 24
$1.7M
$-756.0K
Q3 24
$1.4M
$1.7M
Q2 24
$2.0M
$343.0K
Q1 24
$1.3M
$-1.7M
Gross Margin
FRPH
FRPH
RMTI
RMTI
Q4 25
21.1%
Q3 25
14.3%
Q2 25
15.6%
Q1 25
16.1%
Q4 24
14.7%
Q3 24
22.0%
Q2 24
17.6%
Q1 24
13.5%
Operating Margin
FRPH
FRPH
RMTI
RMTI
Q4 25
15.4%
-2.2%
Q3 25
12.6%
-9.9%
Q2 25
15.3%
-8.4%
Q1 25
22.6%
-7.2%
Q4 24
27.7%
-2.1%
Q3 24
29.0%
6.8%
Q2 24
26.9%
2.0%
Q1 24
28.4%
-5.8%
Net Margin
FRPH
FRPH
RMTI
RMTI
Q4 25
1.3%
-3.0%
Q3 25
6.1%
-11.0%
Q2 25
5.3%
-9.3%
Q1 25
16.6%
-8.0%
Q4 24
16.0%
-3.1%
Q3 24
12.8%
5.9%
Q2 24
19.5%
1.3%
Q1 24
12.8%
-7.6%
EPS (diluted)
FRPH
FRPH
RMTI
RMTI
Q4 25
$0.03
$-0.01
Q3 25
$0.03
$-0.05
Q2 25
$0.03
$-0.05
Q1 25
$0.09
$-0.04
Q4 24
$0.09
$-0.02
Q3 24
$0.07
$0.04
Q2 24
$0.11
$0.01
Q1 24
$0.07
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FRPH
FRPH
RMTI
RMTI
Cash + ST InvestmentsLiquidity on hand
$10.7M
Total DebtLower is stronger
$192.6M
Stockholders' EquityBook value
$428.5M
$37.0M
Total Assets
$735.1M
$57.1M
Debt / EquityLower = less leverage
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FRPH
FRPH
RMTI
RMTI
Q4 25
$10.7M
Q3 25
$134.9M
$13.6M
Q2 25
$153.2M
$12.5M
Q1 25
$142.9M
$11.4M
Q4 24
$148.6M
$15.7M
Q3 24
$144.7M
$12.3M
Q2 24
$156.9M
$11.9M
Q1 24
$152.5M
$6.6M
Total Debt
FRPH
FRPH
RMTI
RMTI
Q4 25
$192.6M
Q3 25
$185.3M
Q2 25
$180.4M
Q1 25
$178.3M
Q4 24
$178.9M
Q3 24
$178.8M
Q2 24
$178.8M
Q1 24
$178.7M
Stockholders' Equity
FRPH
FRPH
RMTI
RMTI
Q4 25
$428.5M
$37.0M
Q3 25
$427.7M
$37.0M
Q2 25
$426.7M
$30.4M
Q1 25
$425.2M
$31.5M
Q4 24
$423.1M
$32.6M
Q3 24
$420.9M
$29.1M
Q2 24
$419.1M
$23.5M
Q1 24
$416.1M
$20.6M
Total Assets
FRPH
FRPH
RMTI
RMTI
Q4 25
$735.1M
$57.1M
Q3 25
$731.3M
$57.5M
Q2 25
$722.8M
$52.6M
Q1 25
$717.1M
$54.0M
Q4 24
$728.5M
$59.2M
Q3 24
$726.9M
$57.1M
Q2 24
$711.9M
$53.0M
Q1 24
$705.7M
$50.7M
Debt / Equity
FRPH
FRPH
RMTI
RMTI
Q4 25
0.45×
Q3 25
0.43×
Q2 25
0.42×
Q1 25
0.42×
Q4 24
0.42×
Q3 24
0.42×
Q2 24
0.43×
Q1 24
0.43×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FRPH
FRPH
RMTI
RMTI
Operating Cash FlowLast quarter
$29.7M
$2.3M
Free Cash FlowOCF − Capex
$-21.5M
$2.2M
FCF MarginFCF / Revenue
-196.6%
12.0%
Capex IntensityCapex / Revenue
468.5%
0.5%
Cash ConversionOCF / Net Profit
213.50×
TTM Free Cash FlowTrailing 4 quarters
$-34.4M
$-1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FRPH
FRPH
RMTI
RMTI
Q4 25
$29.7M
$2.3M
Q3 25
$8.1M
$-1.3M
Q2 25
$8.7M
$1.8M
Q1 25
$4.5M
$-3.5M
Q4 24
$29.0M
$865.0K
Q3 24
$6.3M
$4.3M
Q2 24
$12.2M
$1.4M
Q1 24
$2.9M
$-2.4M
Free Cash Flow
FRPH
FRPH
RMTI
RMTI
Q4 25
$-21.5M
$2.2M
Q3 25
$-16.9M
$-1.5M
Q2 25
$2.6M
$1.7M
Q1 25
$1.4M
$-3.5M
Q4 24
$-22.2M
$470.0K
Q3 24
$-28.2M
$4.1M
Q2 24
$5.9M
$1.2M
Q1 24
$-3.3M
$-2.5M
FCF Margin
FRPH
FRPH
RMTI
RMTI
Q4 25
-196.6%
12.0%
Q3 25
-157.0%
-9.6%
Q2 25
24.0%
10.5%
Q1 25
13.6%
-18.8%
Q4 24
-210.9%
1.9%
Q3 24
-265.7%
14.4%
Q2 24
56.0%
4.5%
Q1 24
-32.6%
-11.1%
Capex Intensity
FRPH
FRPH
RMTI
RMTI
Q4 25
468.5%
0.5%
Q3 25
232.0%
1.4%
Q2 25
55.9%
1.0%
Q1 25
30.1%
0.3%
Q4 24
486.1%
1.6%
Q3 24
325.1%
0.7%
Q2 24
60.3%
1.1%
Q1 24
61.2%
0.6%
Cash Conversion
FRPH
FRPH
RMTI
RMTI
Q4 25
213.50×
Q3 25
12.21×
Q2 25
15.00×
Q1 25
2.63×
Q4 24
17.18×
Q3 24
4.65×
2.57×
Q2 24
5.96×
4.20×
Q1 24
2.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FRPH
FRPH

Other$5.6M51%
Multifamily Segment$5.3M49%

RMTI
RMTI

US$15.9M87%
Non Us$2.4M13%

Related Comparisons